Global Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market to Reach USD 227.88 Million by 2032 | DelveInsight

According to DelveInsight's latest report, "Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market by Product Type, Power Source, End-User, and Geography," the global market is projected to grow at a steady compound annual growth rate (CAGR) of 5.36% during the forecast period from 2025 to 2032. The market, valued at USD 150.65 million in 2024, is anticipated to reach USD 227.88 million by 2032, driven by the increasing prevalence of cardiovascular diseases, rising awareness, government health initiatives, and ongoing innovations in automated CPR technologies.

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market Overview
Automatic mechanical cardiopulmonary resuscitation (CPR) devices are designed to provide consistent, high-quality chest compressions automatically to patients experiencing cardiac arrest. These devices ensure continuous blood circulation to the brain and other vital organs when the heart stops beating, improving survival outcomes during cardiac emergencies. Unlike manual CPR, which can be affected by human fatigue or inconsistent compression depth, mechanical CPR systems deliver precise and uninterrupted compressions.
The growing global burden of cardiovascular diseases (CVDs) and cardiac arrest is creating a strong demand for these automated solutions. Healthcare professionals, emergency responders, and hospitals are increasingly adopting mechanical CPR devices to improve clinical outcomes and standardize care.

Download your complimentary sample report to explore market forecasts, competitive landscape, and the latest innovations driving this USD 227.88 million industry - https://www.delveinsight.com/report-store/automatic-mechanical-cardiopulmonary-resuscitation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market Dynamics
According to the British Heart Foundation (2024), an estimated 640 million people worldwide are living with heart and circulatory conditions. The most common cardiovascular diseases include coronary heart disease (affecting 250 million people), peripheral arterial disease (110 million cases), stroke (94 million), and atrial fibrillation (53 million). This growing incidence of CVDs significantly increases the risk of cardiac arrest, which requires immediate and effective intervention.

The National Institutes of Health (2023) estimated that over 64 million people experienced cardiac arrest globally in 2023. This alarming figure underscores the need for rapid, efficient resuscitation methods. Automated CPR devices are increasingly seen as a critical component in emergency care, as they deliver consistent chest compressions and reduce the limitations of manual CPR.
In addition to medical necessity, rising awareness and government-led initiatives are helping accelerate market adoption. The World Health Organization (WHO) and U.S. Centers for Disease Control and Prevention (CDC) launched the Global Hearts Initiative in 2016 to combat cardiovascular diseases worldwide. Similarly, the World Heart Federation's World Heart Day, observed every September, aims to promote cardiovascular health and reduce the global burden of heart disease.

The aging global population is another key growth factor. According to the United Nations (2023), the number of people aged 65 years and above is expected to double from 761 million in 2021 to 1.6 billion by 2050. Since older adults are more vulnerable to cardiac and respiratory failure, the demand for automated mechanical CPR devices continues to rise in both hospital and pre-hospital settings.
Furthermore, ongoing research and development efforts are fostering technological innovation in this space. For example, Defibtech launched the ARM XR in April 2023, an advanced CPR device designed for use by emergency medical professionals during cardiac arrest. Such product introductions are helping improve device performance, portability, and safety, thereby expanding their clinical use.

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Challenges and Barriers
Despite positive growth trends, certain factors could restrict market expansion. Complications and safety concerns, such as improper device alignment, injury risk, and equipment malfunction, remain key issues. Inadequate staff training and unfamiliarity with device setup can also hinder adoption, particularly in low-resource healthcare settings. Moreover, the high initial cost of automated CPR devices may pose affordability challenges for smaller hospitals and emergency units.

Leverage DelveInsight's data-driven analysis to understand where the next wave of growth in automated CPR technology will emerge - https://www.delveinsight.com/sample-request/automatic-mechanical-cardiopulmonary-resuscitation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market Segmentation
By Product Type:
The automatic mechanical CPR devices market is categorized into load-distributing band (LDB) devices and pneumatic piston devices.
Among these, load-distributing band devices are expected to dominate the market in 2024. Their popularity stems from their ability to deliver circumferential chest compressions that reduce localized rib and organ injury risks. These devices provide consistent, high-quality compressions that maintain adequate coronary and cerebral perfusion pressures, enhancing patient survival chances during cardiac arrest.

A notable example is the LUCAS 2® by Stryker, which performs automated compressions at a consistent rate of 102 compressions per minute and a depth of 5.3 cm (2.1 inches). Its precision and reliability have made it one of the most trusted devices among emergency medical professionals globally.

By Power Source:
The market is segmented into battery-operated and electrically-operated devices. Battery-operated systems are gaining traction due to their mobility and ease of use, especially in ambulance and pre-hospital scenarios where electrical outlets may not be available.

By End-User:
Hospitals account for the largest share of the market, followed by ambulatory surgical centers and other healthcare facilities. The increasing number of emergency admissions and cardiac procedures has driven hospitals to adopt automated CPR systems to ensure uniform resuscitation quality.

Get a snapshot of market growth, key trends, and regional performance. Find out how innovations in CPR automation are redefining emergency cardiac care globally - https://www.delveinsight.com/sample-request/automatic-mechanical-cardiopulmonary-resuscitation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Regional Insights
North America dominates the global automatic mechanical CPR devices market in 2024 and is expected to maintain its leadership throughout the forecast period. This growth is fueled by high cardiovascular disease prevalence, a large aging population, well-established healthcare infrastructure, and the strong presence of major market players.

According to the Centers for Disease Control and Prevention (CDC, 2024), around 6.2 million adults in the U.S. live with heart disease. Similarly, Government of Canada data (2022) reported that approximately 2.6 million Canadians suffer from heart disease. These high numbers contribute to a growing demand for automated CPR solutions that ensure timely and effective resuscitation.
The Heart Failure Society of America (2024) predicts that heart failure cases in Americans aged 20 and older will rise from 6.7 million in 2024 to 11.4 million by 2050. In Canada, the Heart and Stroke Foundation (2022) estimated approximately 60,000 cardiac arrests occur annually. Such trends underscore the need for efficient resuscitation technologies like automatic mechanical CPR systems.

Government programs such as Million Hearts® in the U.S. and public awareness campaigns during American Heart Month are further driving adoption. These initiatives emphasize early response and improved cardiac emergency management, fostering wider acceptance of automated CPR technologies.

Key Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market Players
Prominent Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices companies operating in the market include: Stryker, Asahi Kasei Corporation, Ambu A/S, Michigan Instruments, CPR Medical Devices Inc., Zhuhai Kindway Medical Science & Technology Co., Ltd., Corpuls, Defibtech LLC, SCHILLER AG, Laerdal Medical, SunLife Science, Ambulanc (Shenzhen) Tech Co., Ltd., Henan Maisong Medical, Shenzhen Bangvo Technology Co., Ltd., NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., BIOTRONIK, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., MEDIANA Co., Ltd., and HeartSine Technologies, Ltd.
In March 2025, ReNew Biomedical partnered with Defibtech to provide service support for the ARM XR device. The partnership aims to streamline maintenance, repair, and distribution operations, ensuring the device's consistent availability and performance in emergency care settings.

Gain in-depth insights into leading players, technology trends, and regional dynamics fueling market expansion through 2032 - https://www.delveinsight.com/sample-request/automatic-mechanical-cardiopulmonary-resuscitation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Future Outlook
The automatic mechanical CPR devices market is set for strong, steady growth through 2032. Rising cardiovascular disease rates, increasing adoption of automated medical technologies, and proactive government initiatives will continue to support this momentum. Technological innovations improving device portability, battery life, and compression precision are expected to make these systems a standard part of advanced cardiac life support protocols in hospitals and emergency medical services worldwide.

However, overcoming challenges such as device cost, user training, and safety assurance will be crucial for achieving widespread adoption. Market players focusing on affordability, user-friendly design, and robust training programs are likely to capture a significant competitive advantage.

Key Takeaways from the Report
• Market Value (2024): USD 150.65 million
• Forecast Value (2032): USD 227.88 million
• CAGR (2025-2032): 5.36%
• Leading Segment: Load-distributing band devices
• Dominant Region: North America
• Key Growth Drivers: Rising cardiac arrest cases, aging population, and technological advancements

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.